Literature DB >> 10695858

Viscosupplementation for osteoarthritis.

K E Wright1, S G Maurer, P E Di Cesare.   

Abstract

Viscosupplementation therapy can restore the elastic and viscous properties of synovial fluid and thus recreate the intra-articular joint homeostasis that is disrupted in the degenerative joint. Hyaluronan (hyaluronic acid) products have been developed and used for viscosupplementation therapy in osteoarthritis. Viscosupplementation treatments using these products are well tolerated. Because viscosupplementation therapy is based on the concept of replenishing a normal physiological component of synovial fluid and cartilaginous tissue, exogenous administration of hyaluronic acid has the potential to have few side effects or local or systemic reactions. Viscosupplementation represents an alternative treatment for patients with osteoarthritis in which oral medications and/or surgery are not options or are ineffective.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10695858

Source DB:  PubMed          Journal:  Am J Orthop (Belle Mead NJ)        ISSN: 1078-4519


  4 in total

1.  The treatment of knee cartilage lesions: state of the art.

Authors:  Giuseppe Talesa; Francesco Manfreda; Valerio Pace; Paolo Ceccarini; Pierluigi Antinolfi; Giuseppe Rinonapoli; Auro Caraffa
Journal:  Acta Biomed       Date:  2022-08-31

2.  Analgesic activity of a polysaccharide in experimental osteoarthritis in rats.

Authors:  Rondinelle Ribeiro Castro; Judith Pessoa Andrade Feitosa; Pablyana Leila Rodrigues da Cunha; Francisco Airton Castro da Rocha
Journal:  Clin Rheumatol       Date:  2007-01-11       Impact factor: 3.650

3.  Intra-articular hyaluronic Acid as treatment in elderly and middle-aged patients with knee osteoarthritis.

Authors:  Demet Uçar; Demirhan Dıraçoğlu; Türker Süleyman; Nalan Capan
Journal:  Open Rheumatol J       Date:  2013-07-12

Review 4.  Repair of Damaged Articular Cartilage: Current Approaches and Future Directions.

Authors:  Ekaterina V Medvedeva; Ekaterina A Grebenik; Svetlana N Gornostaeva; Vladimir I Telpuhov; Aleksey V Lychagin; Peter S Timashev; Andrei S Chagin
Journal:  Int J Mol Sci       Date:  2018-08-11       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.